» Articles » PMID: 25723497

Description and Utilization of the United States Department of Defense Serum Repository: a Review of Published Studies, 1985-2012

Overview
Journal PLoS One
Date 2015 Feb 28
PMID 25723497
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Specimens in the United States Department of Defense (DoD) Serum Repository have accumulated in frozen storage since 1985 when the DoD began universal screening for human immunodeficiency virus. Use of the stored serum for health research has been carefully controlled, but the resulting publications have never been systematically identified or described. The Armed Forces Health Surveillance Center (AFHSC) information systems and open (online) sites were used as data sources. Through 2012, the repository contained 54,542,658 serum specimens, of which 228,610 (0.42%) have been accessed for any purpose. Between 2001 (the first year that comprehensive, digital records were available) and 2012, 65.2% of all approved requests for serum were for healthcare or public health investigations, but greater than 99% of all shipped samples were for research. Using two different methods - a structure search of PubMed and an exhaustive online search based on records from AFHSC - we identified 76 articles published between October 1988 and March 2013 that covered a multitude of infectious diseases, injuries, environmental exposures and mental health conditions through analysis of antibodies, biological metabolic, signaling and regulatory substances, Vitamin D, organochlorines, dioxin, omega-3-fatty acid, and portions of human deoxyribonucleic acid. Despite its operational and scientific value, it appears that the DoD Serum Repository has been underutilized. Changes to policy and increased capacity for specimen processing could increase use of the repository without risking privacy or the availability of specimens for the healthcare of individual service members in the future.

Citing Articles

Serum concentrations of persistent endocrine-disrupting chemicals in U.S. military personnel: A comparison by race/ethnicity and sex.

Alcover K, McAdam J, Denic-Roberts H, Byrne C, Sjodin A, Davis M Int J Hyg Environ Health. 2025; 265:114540.

PMID: 39978232 PMC: 11884994. DOI: 10.1016/j.ijheh.2025.114540.


Multi-Autoantibody Testing Identifies Expansion of Reactivity to Targeted Antigens Before a Diagnosis of Rheumatoid Arthritis.

Goff S, Bergstedt D, Feser M, Moss L, Mikuls T, Edison J ACR Open Rheumatol. 2024; 6(9):587-597.

PMID: 38950890 PMC: 11506557. DOI: 10.1002/acr2.11704.


Organochlorine pesticides and risk of papillary thyroid cancer in U.S. military personnel: a nested case-control study.

Rusiecki J, McAdam J, Denic-Roberts H, Sjodin A, Davis M, Jones R Environ Health. 2024; 23(1):28.

PMID: 38504322 PMC: 10949709. DOI: 10.1186/s12940-024-01068-0.


Endocrine disrupting chemical mixture exposure and risk of papillary thyroid cancer in U.S. military personnel: A nested case-control study.

Denic-Roberts H, McAdam J, Sjodin A, Davis M, Jones R, Ward M Sci Total Environ. 2024; 922:171342.

PMID: 38428594 PMC: 11034764. DOI: 10.1016/j.scitotenv.2024.171342.


Elevated serum TARC levels precede classic Hodgkin lymphoma diagnosis by several years.

Diepstra A, Nolte I, van den Berg A, Magpantay L, Martinez-Maza O, Levin L Blood. 2023; 142(22):1928-1931.

PMID: 37748137 PMC: 10733822. DOI: 10.1182/blood.2023020959.


References
1.
Arbuckle M, James J, Kohlhase K, Rubertone M, Dennis G, Harley J . Development of anti-dsDNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus. Scand J Immunol. 2001; 54(1-2):211-9. DOI: 10.1046/j.1365-3083.2001.00959.x. View

2.
Stretch R, Bliese P, Marlowe D, Wright K, Knudson K, Hoover C . Physical health symptomatology of Gulf War-era service personnel from the states of Pennsylvania and Hawaii. Mil Med. 1995; 160(3):131-6. View

3.
Arbuckle M, McClain M, Rubertone M, Scofield R, Dennis G, James J . Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003; 349(16):1526-33. DOI: 10.1056/NEJMoa021933. View

4.
Preston D, Levin L, Jacobson D, Jacobsen S, Rubertone M, Holmes E . Prostate-specific antigen levels in young white and black men 20 to 45 years old. Urology. 2000; 56(5):812-6. DOI: 10.1016/s0090-4295(00)00764-0. View

5.
Burke D, Brundage J, Redfield R, Damato J, Schable C, Putman P . Measurement of the false positive rate in a screening program for human immunodeficiency virus infections. N Engl J Med. 1988; 319(15):961-4. DOI: 10.1056/NEJM198810133191501. View